PreSep 抗菌血氧监测导管

使用创新性抗菌^††材料的连续 ScvO2 监测

抗菌血氧监测导管，具有可连续监测血氧饱和度（ScvO2）的增强功能

采用连续 ScvO2 以识别不明显的组织缺氧^1-3
采用Oligon技术以提供持久的广谱抗菌保护⁴

揭示传统生命体征无法显示的隐伏的组织缺氧^1-3

多达 50% 的休克复苏病人有可能继发全身组织缺氧，尽管其生命体征和 CVP^1-3 已恢复正常。
ScvO2 在失血监测中比传统生命体征更灵敏和有效⁵

现在，利用新增加的 Oligon 抗菌材料的优点

释放银离子（Ag+）的聚合物不会像抗菌涂层那样被冲刷掉
可防止感染革兰氏阴性菌、革兰氏阳性菌以及真菌和耐药微生物菌株
在一项于十所机构进行的前瞻性随机试验中，该导管的细菌定植率与标准导管比较有显著下降⁴
在随后的替代抗菌导管研究中，与导管有关的感染降低了48% ⁶

参考文献：
1. Rivers EP, et al. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care 2001;7(3):204-11.
2. Reinhart K, et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med 2004; 30(8):1572-8.
3. Ingelmo P, et al. Importance of monitoring in high risk surgical patients. Minerva Anestesiol 2002;68(4):226-30.
4. Ranucci M, et al. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 2003;31(1):52-9.
5. Scalea TM, et al. Central venous oxygen saturation: a useful clinical tool in trauma patients. J Trauma 1990;30:1539-43
6. Garcia, R, et al. Three years experience in implementing HICPAC recommendations for the reduction of central venous catheter-related bloodstream infections. Poster presentation at National APIC meeting, June 2003

†† The activity of the antimicrobial agent is localized at the catheter surfaces and is not intended for treatment of systemic infections. In vitro testing demonstrated that the Oligon material provided broad?spectrum effectiveness (= 3 log reduction from initial concentration within 48 hours) against the organisms tested: Staphylococcus aureus, Staphylococcus epidermidis, Klebsiella pneumoniae, Enterococcus faecalis, Candida albicans, Escherichia coli, Serratia marcescens, Acinetobacter calcoaceticus, Corynebacterium diphtheriae, Enterobacter aerogenes, GMRSa, Pseudomonas aeruginosa, Candida glabrata and VRE (Enterococcus faecium).